404. Deputy Mattie McGrath asked the Minister for Health the measures he is taking to address concerns that diagnoses of foetal anti-convulsant syndrome are still being made due to inadequate levels of public awareness in relation to the use of valproate medicines; the number of children diagnosed with the syndrome for each of the past four years; and if he will give consideration to introducing a financial redress scheme for persons with the condition. [47930/18]

Summary

404. Deputy Mattie McGrath asked the Minister for Health the measures he is taking to address concerns that diagnoses of foetal anti-convulsant syndrome are still being made due to inadequate levels of public awareness in relation to the use of valproate medicines; the number of children diagnosed with the syndrome for each of the past four years; and if he will give consideration to introducing a financial redress scheme for persons with the condition. [47930/18]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 20 November 2018

   Medicinal Products Regulation

   404. Deputy Mattie McGrath asked the Minister for Health the measures he is taking to address concerns that diagnoses of foetal anti-convulsant syndrome are still being made due to inadequate levels of public awareness in relation to the use of valproate medicines; the number of children diagnosed with the syndrome for each of the past four years; and if he will give consideration to introducing a financial redress scheme for persons with the condition. [47930/18]

   Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Regulation

  xml · EN · 20 November 2018

  ViewDownloadOpen at official source

Sponsors

• McGrath, Mattie. · Asking member
• Health · Health · Addressed to

Related records

No cross-record relationships stored yet.